Healthcare
VRTX
Vertex Pharmaceuticals Incorpor
$438.71-1.91%
Conviction Score
61/100
Data aggregation, not advice
About Vertex Pharmaceuticals Incorpor
Vertex Pharmaceuticals dominates the cystic fibrosis drug market. Their treatments have transformed the lives of patients with this genetic disease. The company is expanding into pain management and other rare diseases. They have one of the strongest growth profiles in biotech.
Full research is for ConvictionStocks members
Unlock Full AccessScore Breakdown
How each category contributes to the overall Conviction Score.
Full research is for ConvictionStocks members
Unlock Full AccessWhat Analysts Think
Full research is for ConvictionStocks members
Unlock Full AccessRecent News
Full research is for ConvictionStocks members
Unlock Full AccessRelated Research
More Healthcare stocks to explore